Professional Documents
Culture Documents
Module 3: Specimen Collection and Processing: Analytical Errors: Errors Made During The Testing
Module 3: Specimen Collection and Processing: Analytical Errors: Errors Made During The Testing
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 10
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 11
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
i. COMPLICATIONS OF VENIPUNCTURE
• Immediate Local
o Hemoconcentration
▪ Increase in the number of formed elements in
the blood
▪ Plasma volume
• Decrease: polycythemia
• Increase: Anemia
o Failure of blood to enter the syringe/vacutainer tube
▪ Excessive pull of plunger
▪ Piercing the other hole of the vein
▪ Transfixation of vein
▪ Incorrect bevel position
▪ Absence of vacuum
o Hematoma
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 12
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
▪ Failure to remove the tourniquet before • Indwelling umbilical artery catheter: best method for
withdrawing the needle Blood Gas Collection
▪ Failure to have the needle completely in the • best to warm site to dilate the vessels and increase blood
vein flow
▪ Repeat puncture of the vein o Warming: should not exceed 10 mins or it may
▪ Failure to apply pressure to the wound in alter results
sufficient amt. of time • Incision depth:
▪ Excess probing to obtain blood o Infant: < 2mm
o Circulatory Failure o Adults: < 2.5 mm
o Syncope (fainting) • Sites not recommended:
▪ Increases anxiety o Central arch of infant’s heel
• Late Local o Fingers of newborn or infant (one year old or below)
o Thrombosis (clot) o Thumb, index and 5th finger
▪ Abnormal vascular condition in which a o Fingers on side with mastectomy
thrombus develops within the blood vessel of o Scarred sites
the body
o Thrombophlebitis i. ORDER OF DRAW
▪ inflammation of a vein often accompanied by a
clot as a result of trauma to the vessel wall
• Late General Order of Draw Additives Inversion/mixing
o Blood borne infections Capillary Blood Gas Heparin Rotate between
palms
o Hepatitis
Blood Smears N/A 10
o AIDS
Lavender top EDTA 10
• Nerve Injury Heparinized Lithium Heparin 10
o The factors associated with nerve injury in blood Plasma Separator Lithium Heparin with 10
collection are preventable and include Tubes gel separator
▪ Improper vein selection Oxalate/ Fluoride Sodium fluoride with 10
▪ Using jerky movements Tubes Potassium oxalate
▪ Inserting the needle too far Serum tube with Clot activator 5
▪ Movement by the patient while the needle is in additives
the vein Serum tube without N/A 0
▪ Lateral redirection of the needle additives
Newborn Screening Use spot/filter cards 0
▪ Blind probing (blind chat)
o maybe temporary or permanent • Order of Draw important: platelets accumulate at the site
▪ Symptoms: of puncture
→ tingling or burning or electric shock • Last specimen
→ Pain felt up and down the arm and
• Phlebotomy Complications (Turgeon) ii. BLOOD SPOT COLLECTION
o Vascular complications • Blood should be collected
▪ most common o 1 to 3 days after birth (at least 24hrs after birth)
o Infection • Collection is done by heel puncture
▪ second most common • Neonatal screening program: PKU, galactosemia,
o Anemia hyperthyroidism, hemoglobinopathies
▪ iatrogenic (nosocomial) anemia • Lancet: no longer than 2.4 mm to avoid injury to the
o Neurological complications calcaneus or heelbone
▪ seizure or pain
o Cardiovascular
▪ orthostatic hypotension
▪ syncope shock
▪ cardiac arrest
o Dermatological
▪ allergic reaction to iodine
E. CAPILLARY/SKIN PUNCTURE
• Rarely done in chemistry
• Also known as Capillary puncture or microsampling
• Used when only a small amount of blood sample is
needed
• Cut must be made across or perpendicular to the
fingerprint ridges to facilitate good blood flow
• First drop should be wiped off
• Milking process is not allowed
• Preferred sites:
o Lateral plantar heel surface
▪ Common in infants
▪ Avoid hitting calcaneus bone/heelbone
o Plantar surface of the big toe, lateral side of the finger
adjacent to the nail, earlobe (least)
▪ Common in children
o Palmar surfaces of fingers 3rd and 4th
▪ Common in adults
o Earlobes
▪ Least preffered site
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 13
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
B. ANTICOAGULANTS
1. Oxalate
III. SPECIMEN PRESERVATION AND • Mechanism of Action: combines with calcium to form an
ANTICOAGULANTS insoluble salt
• Tube additives • Types: Na, K, ammonium, lithium, or dioxalate
o Preserve a specific blood constituent o Lithium oxalate: best type; used for plasma uric
o Aid in the separation of serum from cell acid
• Reasons for rapid separation of serum: o Na oxalate: prothrombin tests (routine)
o To prevent glycolysis o K oxalate: caused variable dilution of plasma due
o To prevent lipolysis to H2O transports
o Certain substance are very unstable ▪ Shrinks RBC = not use to measure hematocrit
o To prevent shift of electrolytes • Interferes with Na, K, BUN tests
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 14
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
• Inhibits: lactate dehydrogenase (LDH), acid citrate o prevents glycolysis for 24 hours
phosphatase, amylase
• Used as dried: 6. Heparin
o Should be dried as a thin film on the wall of the vial • Mechanisms of action: antithrombin (accelerates) and
= minimize hemolysis antithromboplastin (neutralizes thrombin, prevent fibrin
o Tempt of drying: should not exceed 100°C formation)
▪ otherwise, oxalate CONVERTS TO • Total calcium determination in lack of serum or plasma
carbonate = no anticoagulant property • Advantages:
• Concentration: o Ideal universal anticoagulant; least interference
o 1-2 mg/mL of blood (K oxalate) with analysis
o 0.01 mL of aq. 20% solution per mLof blood o Minimal chelating properties
o 1 gt per mL of blood o Minimal effects on H2O shifts
o Low cation concentration
2. Citrate • Disadvantages:
• Mechanism of action: combines with calcium in a non- o Interferences: some immunoassays
ionized soluble form ▪ Not used for coagulation and hematology
• Citrate: inhibits amylase activity testing
• Coagulation studies; ESR determination (black top) • Uses:
• Na Citrate o pH or blood gas analysis
o Black Top o ammonia determination
▪ Buffered citrate: stabilizes plasma pH o carboxy, methemoglobin determination
▪ Used for Westergren ESR o ionized calcium
o Light Blue Top: o cytogenic studies
▪ Coagulation testing: preserves the labile • Cytogenetic studies
coagulation factors • Types: Na, K, Lithium, and ammonium salts
• Concentration: • Concentration:
o 3.2-3.8 g/dL o 0.2 mg/mL of blood
▪ Light blue top – 0.105M (3,2%) or 0.129M ,1:9 • Heparinized plasma
(ratio of anticoagulant to blood) o Used for Potassium measurements: avoid an
▪ Black top –1:4, 0.129 M (3.8%) elevation due to the release of potassium from
platelets as blood clots
3. Acid Citrate Dextrose (ACD) • Lithium heparin
• Dextrose o For chem tests EXCEPT lithium and folic levels
• Used for blood transfusion; non-toxic • Sodium heparin
• Rapidly utilized by the body; easily excreted by the o Can’t use for sodium tests, assays
kidneys o Recommended: trace elements (lead, toxicology)
• Dextrose o Injectable form: anticoagulant therapy
o Added as a source of energy to prolong the
lifespan of RBC during storage 7. Sodium Polyanethol Sulfonate (SPS)
o Concentration: 5 mg/mL of blood • Concentration:
o 1 to 2.5 mg/mL of blood
4. EDTA (ethylenediaminetetraaceticacid)
• Mechanism of action: combines with calcium (chelation) 8. Glass Beads
• Uses • Mechanical means of preventing coagulation
o Primary: Hematology
o Blood Banking, CEA (carcinoembryonic antigen), 9. Red Top Tubes
lead testing • No additives
o Hb1Ac • Most Chemistry, Blood Bank, and Immunology assays
• Two forms: • Serum samples
o Versene: disodium (Na2EDTA)
o Sequestrene: dipotassium (K2EDTA)
10. Red/Gray and Gold tubes
• Concentration:
• Contain a clot activator and separation gel
o 1-2 mg/mL of blood
• Referred to as SST
• Inappropriate: enzyme analysis
o Binding of metal cofactor necessary for enzyme • Advantages
action o Ease to use
o Shorter processing time to clot activation
5. Sodium Fluoride o Higher serum yield compared to the ordinary RED
TOP
• Mechanism of action: forms weakly dissociated calcium
o Minimal liberation of potentially hazardous
components
aerosols upon separation of serum
• Glucose measurement
o Only one centrifugation step is required
• For Glucose Testing o Use of the same tube/mother tube px sample
• Bacterial septicemia: originally drawn with the case of single labelling
o Fluoride inhibition is neither adequate nor effective in
preserving glucose formation
• Concentration:
o 10 mg/mL of blood
• Sodium fluoride
o prevents glycolysis for 3 days
o Inhibits: glycolytic enzyme, enolase, glucose oxidase
o ↑ amylase activity, ↓ ACP activity
o Interferes to: Na, K, BUN testing
• Lithium iodoacetate
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 15
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
C. ORDER OF DRAW
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 16
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 17
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 18
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
Bloody Malignancy, traumatic tap, tuberculosis o Provides a protective cushion for the fetus
o Allows the movement of the fetus
Milky Lymphatic trauma and blockage o Exchange of nutrients between mother and
fetus
ii. CHEMICAL EXAMINATION o Regulates the temperature of the fetal
environment
1. Glucose
o Decreased in tuberculosis and malignancy • Amniocentesis
2. Enzymes • Also known as amniotic sac puncture
o LDH – malignancy • Method of amniotic fluid collection
o AMS – pancreatitis, GIT perforation, • Can be transabdominal or transplacental
intestinal necrosis • Maximum of 30 mL
o ALP – intestinal perforation • Centrifugation should be done at low speed
3. Lactate
o Elevated in spontaneous bacterial peritonitis, • 500-1000g for 5 minutes to get supernatant and
sediment
malignancy and tuberculosis
4. BUN and Creatinine • Preservation depends on tests to be performed
o Ruptured bladder • Fetal lung maturity: ice or refrigerated
5. Ammonia • Cytogenetic analysis: room temperature or 37
o Perforated peptic ulcer, ruptured appendix, degrees
bowel strangulation, ruptured bladder • Hemolytic Disease of the Newborn: protect from
6. Serum ascites-albumin gradient(SAAG) light
o Transudate: >1.1
o Exudate: <1.1 COLOR AND APPEARANCE
7. Tumor markers
o CEA and CA125 Normal Colorless
Traumatic tap or
F. SYNOVIAL FLUID Blood-streaked
hemorrhage
• Viscous fluid in the cavities of movable joints
Hemolytic Disease of the
• Ultrafiltrate of plasma combined with hyaluronic acid Yellow
Newborn
produced by the synovial cells
• Specimen Collection and Handling Dark Green Meconium
o Arthrocentesis- collection procedure Dark Red Brown
o Collected in three tubes like CSF Fetal Death
1. Sterile heparinized: for microbiology Brown
2. Liquid EDTA and Na heparin: microscopic
cell count NORMAL
3. Sodium fluoride: glucose analysis TESTS DISEASES
VALUES
4. Plain tube: for other extra tests
AFP (alpha-
Neural tube defect
i. GROSS EXAMINATION fetoprotein) < 2.0 MoM
• Total volume: <3mL AchE Neural tube defect
• Color: colorless to pale yellow ABO-Rh
• Clarity: clear compatibility
HDN
• Consistency: Viscous and non-clotting OD at 365 nm
Bilirubin
Bilirubin
Assay
ii. CHEMICAL ANALYSIS
1. Glucose L/S Ratio FLM > 2.0 L/S
o Normal value: 0-10 mg/dL lower than serum Foam Ring of bubbles
levels FLM
Stability at > 0.47 mL
o Ratio of synovial fluid to serum glucose: 0.9:1
o Decreased glucose is seen in septic arthritis Fluorescence
FLM > 55 mg/g
2. Protein Polarization
o Normal value: <3 g/dL
o Elevated in inflammatory and hemorrhagic Lamellar > 32,000
FLM
disorders Bodies particles/uL
3. Lactate/ Lactic acid
o Normal value: <25 mg/dL V. SPECIMEN VARIABLES
o Septic arthritis: >250 mg/dL up to 1000 mg/dL Specimen Variables
4. Uric acid • Includes:
o Normal value: 6-mg/dL o physiologic considerations, proper patient
o Used for diagnosis of gout, in cases wherein preparation, and problems in collection,
crystal examination is not available transportation, processing, and storage.
5. Lactate dehydrogenase • Physiologic variation:
o Increased in cases of rheumatoid arthritis, o refers to changes that occur within the body,
infectious arthritis and gout. o cyclic changes (diurnal or circadian variation)
o In case of RA: LDH is abnormal in synovial o those resulting from exercise, diet, stress, gender,
fluid but normal in serum age, underlying medical conditions (e.g., fever,
asthma, obesity), drugs, or posture.
G. AMNIOTIC FLUID • Drugs can affect various analytes.
• Fluid present in the amniotic sac surrounding the • High amounts or chronic consumption of alcohol causes
fetus hypoglycemia
• Functions:
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 19
MODULE 3: SPECIMEN COLLECTION AND PROCESSING
A. PRE-ANALYTICAL
• Personnel Professionalism
• Patient consent
• Patient preparation
• Infection control
• Standard precautions
• Patient identification
• Preparation for venipuncture
• Venipuncture Procedure and other specimen collection
• Proper use of anticoagulant and preservatives
• Specimen Handling and Processing
• Transporting Specimens
• Delivery time limits
B. ANALYTICAL
• Analytic techniques and instrumentation
• Quality Control
• Interferences with the methods
• Specific reagents
• knowledge of the analyte, analytic parameters,
methodology, and instrumentation and management of
all study variables
C. POST ANALYTICAL
• LIS (lab integrated system) and HIS (hospital integrated
system)
• Report should include:
o Unique patient identifier and test name
o the test value with the unit of measure
o date and time of collection
o sample information
o reference ranges
o other pertinent information for proper test
interpretation.
REFERENCES
Notes from the discussion by Ms. Aurea P. Manzon, RMT,
MSMT (c)
CANDAZA, DELA CRUZ, DUBLOIS, GRANADA, LAGUD, MACATUGGAL, MALANA, MELOSANTOS, PANGILINAN, SUELILA, TORRES, ZUÑIGA 20